Treatment of Graves’ Disease During Pregnancy

Abstract

Graves’ disease is an autoimmune syndrome where thyroid stimulating antibodies bind to and activate the thyrotropin receptor on thyroid cells resulting in hyperthyroidism (Weetman, 2000; Jonklaas, 2011). Specifically, the production of thyroid-stimulating immunoglobulin (TSI) and thyroid-stimulating hormone-binding inhibitory immunoglobulin (TBII) act on the thyroid stimulating hormone receptor to cause thyroid stimulation or thyroid inhibition, respectively.

Cite this paper

@inproceedings{Bailey2012TreatmentOG, title={Treatment of Graves’ Disease During Pregnancy}, author={Teresa M. Bailey}, year={2012} }